Several reports, from our lab and others, have demonstrated roles for IGF family members in GIST pathogenesis and response to IM, prompting many groups to begin evaluating the use of IGF inhibitors as a potential therapy for GIST [10], [11], [63], [64]. The gene discussed is IGF1; the disease is gastrointestinal stromal tumor.